The Attitudes of the Patients with the Multisystem Inflammatory Syndrome in Children Secondary to SARS-CoV-2 Regarding COVID-19 Vaccines
Yıl: 2022 Cilt: 7 Sayı: 3 Sayfa Aralığı: 468 - 472 Metin Dili: İngilizce DOI: 10.26453/otjhs.1095563 İndeks Tarihi: 02-09-2022
The Attitudes of the Patients with the Multisystem Inflammatory Syndrome in Children Secondary to SARS-CoV-2 Regarding COVID-19 Vaccines
Öz: Objective: Multisystem inflammatory syndrome (MIS-C) in children is an abnormal immune response that occurs after exposure to SARS-CoV-2. To our knowledge, there is no study demonstrating the efficacy and safety of the BNT162b2 mRNA vaccine in children who were diagnosed with MIS-C previously. In this study, we aimed to present the attitudes of MIS-C patients over the age of 12 years towards the COVID-19 vaccine, and the side effects of the vaccine in vaccinated patients.Materials and Methods: The files of patients who were followed up with the diagnosis of MIS-C between May 2020 and January 2022 aged 12 years and over were reviewed retrospectively.Results: Thirty-six patients (12 girls, 24 boys) were included in the study. The median age was 13.5 (12-17) years. Eight of the 36 patients (22.2%) were vaccinated at a median of 3 (3-6) months after the diagnosis of MIS-C. No side effects or disease reactivation was observed following vaccination. The most common reasons for patients' refusal to be vaccinated were having had the disease and being concerned about a recurrence.Conclusion: This study showed that COVID-19 vaccination was safe in children who were diagnosed with MIS-C, although most of our patients were against it.
Anahtar Kelime: Çocuklarda COVID-19’a İkincil Gelişen Multisistemik İnflamatuar Sendrom Tanılı Hastaların COVID-19 Aşısına Karşı Tutumları
Öz: Amaç: Çocuklarda multisistemik inflamatuar sendrom (MIS-C); SARS-CoV-2 ile enfekte olduktan sonra ortaya çıkan anormal bir bağışıklık yanıtıdır. Bu hastalarda BNT162b2 mRNA aşısının etkinliğini ve güvenliğini ortaya koyan bir çalışma yoktur. Bu çalışmada MIS-C tanısı almış 12 yaşın üzerindeki hastalarımızın COVID-19 aşısına karşı tutumları ve eğer aşılandılarsa gelişen yan etkileri sunmayı amaçladık.Materyal ve Metot: Çalışmada Mayıs 2020-Ocak 2022 tarihleri arasında MIS-C tanısı ile takip edilen 12 yaş ve üzeri olguların dosyaları geriye dönük olarak taranarak hasta ve ailesine ait aşılanma bilgileri edinildi.Bulgular: Çalışmaya 36 hasta (12 kız, 24 erkek) dahil edildi. Ortanca yaşları 13,5 (12-17) yıldı. Sekiz hasta (%22,2) MIS-C tanısından ortanca üç (üç-altı) ay sonra aşı olmuştu. Aşı sonrası herhangi bir yan etki saptanmadı ve hiçbir çocukta hastalık reaktivasyonu olmadı. Hastaların aşı olmayı reddetmelerinin en sık nedenleri; hastalığı geçirmiş olmaları ve hastalığın tekrarlayabileceği korkusuydu.Sonuç: MIS-C tanılı olguların SARS-CoV-2 aşılarına karşı tutumunu değerlendiren bu çalışmada; çoğu hasta ve ebeveynlerinin COVID-19 aşısı olmaya karşı olduğu, aşı olan grupta ise aşının güvenli olduğu gösterildi.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Feldstein LR, Rose EB, Horwitz SM, et al. Mul- tisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383(4):334- 346. doi:10.1056/NEJMoa2021680
- 2. Dufort EM, Koumans EH, Chow EJ, et al. Mul- tisystem inflammatory syndrome in children in New York State. N Engl J Med. 2020;383(4):347 -358. doi:10.1056/NEJMoa2021756
- 3. Centers for Disease Control andPrevention. Mul- tisystem Inflammatory Syndrome in Children (MIS-C) Associated with Corona virus Disease 2019 (COVID-19) 2020. https:// emergency.cdc.gov/han/2020/han00432.asp. Ac- cessed March 20, 2022.
- 4. Hause AM, Baggs J, Marquez P, et al. COVID- 19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December19, 2021. MMWR Morb Mortal Wkly Rep. 2021;70 (5152):1755–1760. doi:10.15585/ mmwr.mm705152a1
- 5. Yousaf AR, Cortese MM, Taylor AW, et al. Reported cases of multisystem inflammatory syndrome in children aged 12-20 years in the USA who received a COVID-19 vaccine, De- cember, 2020, through August, 2021: A surveil- lance investigation. Lancet Child Adolesc He- alth. 2022;6(5): 3030-312. doi:10.1016/S2352- 4642(22)00028-1
- 6. Levy M, Recher M, Hubert H, et al. Multisys- tem inflammatory syndrome in children by COVID-19 vaccination status of adolescents in France. JAMA. 2022;327(3):281-283. doi:10.1001/jama.2021.23262
- 7. Zambrano LD, Newhams MM, Olson SM, et al. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflam- matory syndrome in children among persons aged 12–18 years—United States, July– December 2021. MMWR Morb Mortal Wkly Rep. 2022;71(2):52–58. doi:10.155585/ mmwr.mm7102e1
- 8. Buchhorn R, Meyer C, Schulze-Forster K, Jun- ker J, Heidecke H. Autoantibody release in children after corona virus mRNA vaccination: A risk factor of multisystem inflammatory synd- rome? Vaccines (Basel). 2021;9(11):1353. doi:10.3390/vaccines9111353
- 9. Chin SE, Bhavsar SM, Corson A, Ghersin ZJ, Kim HS. Cardiac complications associated with COVID-19, MIS-C, and mRNA COVID-19 vaccination. Pediatr Cardiol. 2022;43(3):483- 488. doi:10.1007/s00246-022-02851-x
- 10.Centers for Disease Control and Prevention. The vaccine adverse event reporting system (VAERS) results 2021. https://wonder.cdc.gov/ vaers.html. Accessed December 2, 2021.
- 11.Rostad CA, Chahroudi A, Mantus G, et al. Qu- antitative SARS-CoV-2 serology in children with multisystem inflammatory syndrome (MIS- C). Pediatrics. 2020;146:e2020018242. doi:10.1542/peds.2020-018242
- 12.Yonker LM, Neilan AM, Bartsch Y, et al. Pedi- atric severe acute respiratory syndrome corona- virus 2 (SARS-CoV-2): clinical presentation, infectivity, and immune responses. J Pediatr. 2020;227:45–52.e5. doi:10.1016/ j.jpeds.2020.08.037
- 13.Trougakos IP, Terpos E, Zirou C, et al. Compa- rative kinetics of SARS-CoV-2 anti-spike pro- tein RBD IgG s and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients. BMC Med. 2021;19:208. doi:10.1186/ s129-021-02090-6
- 14.T.C. Sağlık Bakanlığı COVID-19 aşısı bilgilen- dirme platformu 2022. https:// covid19asi.saglik.gov.tr/. Accessed March 24, 2022.
- 15.Türkiye Nüfusu Yaş Gruplarına Göre Dağılımı 2021. https://www.nufusu.com/turkiye-nufusu- yas-gruplari. Accessed March 24, 2022.
- 16.Akgün Ö, Çakmak F, Guliyeva V, Demirkan FG, Tanatar A, Hançerli Torun S, Çin D, Meşe S, Ağaçfidan A, Aktay Ayaz N. Rheumatology (Oxford). 2022. doi:10.1093/rheumatology/ keac140
| APA | Başar E, Aydın D, Sönmez H, Babaoğlu K (2022). The Attitudes of the Patients with the Multisystem Inflammatory Syndrome in Children Secondary to SARS-CoV-2 Regarding COVID-19 Vaccines. , 468 - 472. 10.26453/otjhs.1095563 |
| Chicago | Başar Eviç Zeynep,Aydın Dicle,Sönmez Hafize Emine,Babaoğlu Kadir The Attitudes of the Patients with the Multisystem Inflammatory Syndrome in Children Secondary to SARS-CoV-2 Regarding COVID-19 Vaccines. (2022): 468 - 472. 10.26453/otjhs.1095563 |
| MLA | Başar Eviç Zeynep,Aydın Dicle,Sönmez Hafize Emine,Babaoğlu Kadir The Attitudes of the Patients with the Multisystem Inflammatory Syndrome in Children Secondary to SARS-CoV-2 Regarding COVID-19 Vaccines. , 2022, ss.468 - 472. 10.26453/otjhs.1095563 |
| AMA | Başar E,Aydın D,Sönmez H,Babaoğlu K The Attitudes of the Patients with the Multisystem Inflammatory Syndrome in Children Secondary to SARS-CoV-2 Regarding COVID-19 Vaccines. . 2022; 468 - 472. 10.26453/otjhs.1095563 |
| Vancouver | Başar E,Aydın D,Sönmez H,Babaoğlu K The Attitudes of the Patients with the Multisystem Inflammatory Syndrome in Children Secondary to SARS-CoV-2 Regarding COVID-19 Vaccines. . 2022; 468 - 472. 10.26453/otjhs.1095563 |
| IEEE | Başar E,Aydın D,Sönmez H,Babaoğlu K "The Attitudes of the Patients with the Multisystem Inflammatory Syndrome in Children Secondary to SARS-CoV-2 Regarding COVID-19 Vaccines." , ss.468 - 472, 2022. 10.26453/otjhs.1095563 |
| ISNAD | Başar, Eviç Zeynep vd. "The Attitudes of the Patients with the Multisystem Inflammatory Syndrome in Children Secondary to SARS-CoV-2 Regarding COVID-19 Vaccines". (2022), 468-472. https://doi.org/10.26453/otjhs.1095563 |
| APA | Başar E, Aydın D, Sönmez H, Babaoğlu K (2022). The Attitudes of the Patients with the Multisystem Inflammatory Syndrome in Children Secondary to SARS-CoV-2 Regarding COVID-19 Vaccines. Online Türk Sağlık Bilimleri Dergisi, 7(3), 468 - 472. 10.26453/otjhs.1095563 |
| Chicago | Başar Eviç Zeynep,Aydın Dicle,Sönmez Hafize Emine,Babaoğlu Kadir The Attitudes of the Patients with the Multisystem Inflammatory Syndrome in Children Secondary to SARS-CoV-2 Regarding COVID-19 Vaccines. Online Türk Sağlık Bilimleri Dergisi 7, no.3 (2022): 468 - 472. 10.26453/otjhs.1095563 |
| MLA | Başar Eviç Zeynep,Aydın Dicle,Sönmez Hafize Emine,Babaoğlu Kadir The Attitudes of the Patients with the Multisystem Inflammatory Syndrome in Children Secondary to SARS-CoV-2 Regarding COVID-19 Vaccines. Online Türk Sağlık Bilimleri Dergisi, vol.7, no.3, 2022, ss.468 - 472. 10.26453/otjhs.1095563 |
| AMA | Başar E,Aydın D,Sönmez H,Babaoğlu K The Attitudes of the Patients with the Multisystem Inflammatory Syndrome in Children Secondary to SARS-CoV-2 Regarding COVID-19 Vaccines. Online Türk Sağlık Bilimleri Dergisi. 2022; 7(3): 468 - 472. 10.26453/otjhs.1095563 |
| Vancouver | Başar E,Aydın D,Sönmez H,Babaoğlu K The Attitudes of the Patients with the Multisystem Inflammatory Syndrome in Children Secondary to SARS-CoV-2 Regarding COVID-19 Vaccines. Online Türk Sağlık Bilimleri Dergisi. 2022; 7(3): 468 - 472. 10.26453/otjhs.1095563 |
| IEEE | Başar E,Aydın D,Sönmez H,Babaoğlu K "The Attitudes of the Patients with the Multisystem Inflammatory Syndrome in Children Secondary to SARS-CoV-2 Regarding COVID-19 Vaccines." Online Türk Sağlık Bilimleri Dergisi, 7, ss.468 - 472, 2022. 10.26453/otjhs.1095563 |
| ISNAD | Başar, Eviç Zeynep vd. "The Attitudes of the Patients with the Multisystem Inflammatory Syndrome in Children Secondary to SARS-CoV-2 Regarding COVID-19 Vaccines". Online Türk Sağlık Bilimleri Dergisi 7/3 (2022), 468-472. https://doi.org/10.26453/otjhs.1095563 |
